The Factor II Assay measures the concentration and activity of prothrombin or Factor II key cascade protein involved in coagulation. The test is indicated to evaluate recurrent venous thromboembolism and diagnose abnormal clotting due to Factor II deficiencies or mutations. Tests help healthcare providers identify genetic mutations with Factor II deficiency, thrombosis risk assessment, and tailored therapeutic interventions.